BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10973281)

  • 1. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice.
    Garbi N; Tan P; Diehl AD; Chambers BJ; Ljunggren HG; Momburg F; Hämmerling GJ
    Nat Immunol; 2000 Sep; 1(3):234-8. PubMed ID: 10973281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
    Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tapasin enhances MHC class I peptide presentation according to peptide half-life.
    Howarth M; Williams A; Tolstrup AB; Elliott T
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11737-42. PubMed ID: 15286279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense.
    Cerundolo V; de la Salle H
    Semin Immunol; 2006 Dec; 18(6):330-6. PubMed ID: 16973375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.
    Li L; Sullivan BA; Aldrich CJ; Soloski MJ; Forman J; Grandea AG; Jensen PE; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3707-15. PubMed ID: 15356116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of tapasin alters immunodominance against a lymphocytic choriomeningitis virus polytope.
    Boulanger DS; Oliveira R; Ayers L; Prior SH; James E; Williams AP; Elliott T
    J Immunol; 2010 Jan; 184(1):73-83. PubMed ID: 19949070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On cross-priming of MHC class I-specific CTL: rule or exception?
    Zinkernagel RM
    Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer.
    Wearsch PA; Cresswell P
    Nat Immunol; 2007 Aug; 8(8):873-81. PubMed ID: 17603487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of tapasin gene restores surface expression of HLA class I molecules, but not antigen presentation of an HIV envelope peptide in a hepatoma cell line.
    Matsui M; Machida S; Tomiyama H; Takiguchi M; Akatsuka T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):508-17. PubMed ID: 11444872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex.
    Elliott T; Williams A
    Immunol Rev; 2005 Oct; 207():89-99. PubMed ID: 16181329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression.
    Salazar-Onfray F; Petersson M; Franksson L; Matsuda M; Blankenstein T; Kärre K; Kiessling R
    J Immunol; 1995 Jun; 154(12):6291-8. PubMed ID: 7759867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the MHC class I peptide cargo is dependent on tapasin.
    Williams AP; Peh CA; Purcell AW; McCluskey J; Elliott T
    Immunity; 2002 Apr; 16(4):509-20. PubMed ID: 11970875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I antigens, immune surveillance, and tumor immune escape.
    Garcia-Lora A; Algarra I; Garrido F
    J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of action of tapasin in the peptide exchange on MHC class I molecules determined from kinetics simulation studies.
    Schneeweiss C; Garstka M; Smith J; Hütt MT; Springer S
    Mol Immunol; 2009 Jun; 46(10):2054-63. PubMed ID: 19362740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tapasin in MHC class I antigen presentation in vivo.
    Garbi N; Tan P; Momburg F; Hämmerling GJ
    Adv Exp Med Biol; 2001; 495():71-8. PubMed ID: 11774611
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice.
    Grandea AG; Golovina TN; Hamilton SE; Sriram V; Spies T; Brutkiewicz RR; Harty JT; Eisenlohr LC; Van Kaer L
    Immunity; 2000 Aug; 13(2):213-22. PubMed ID: 10981964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?
    Garbi N; Tanaka S; van den Broek M; Momburg F; Hämmerling GJ
    Immunol Rev; 2005 Oct; 207():77-88. PubMed ID: 16181328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH.
    Chefalo PJ; Grandea AG; Van Kaer L; Harding CV
    J Immunol; 2003 Jun; 170(12):5825-33. PubMed ID: 12794107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide.
    Chen X; Liu H; Tang Z; Yu Y; Zang G
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):203-12. PubMed ID: 23299079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.